bioAffinity Technologies, Inc. (BIAF)

NASDAQ: BIAF · IEX Real-Time Price · USD

2.590

-0.410 (-13.67%)

At close: Apr 23, 2024, 4:00 PM

2.710

+0.120 (4.63%)

After-hours: Apr 23, 2024, 6:34 PM EDT

bioAffinity Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	30	14	13	-	-
Market Cap Growth	-	4.34%	-	-	-
Enterprise Value	29	13	2	10	10
PE Ratio	-1.76	-1.76	-1.64	-	-
PS Ratio	11.78	5.52	2788.17	-	-
PB Ratio	6.14	2.88	1.21	-	-
P/FCF Ratio	-2.31	-2.31	-3.12	-	-
P/OCF Ratio	-2.31	-2.31	-3.29	-	-
EV/Sales Ratio	11.29	5.03	464.21	-	-
EV/EBITDA Ratio	-1.67	-1.67	-0.40	-1.88	-1.45
EV/EBIT Ratio	-1.62	-1.62	-0.40	-1.88	-1.44
EV/FCF Ratio	-2.10	-2.10	-0.52	-4.88	-4.49
Debt / Equity Ratio	0.33	0.33	0.02	-0.72	-0.66
Debt / EBITDA Ratio	-0.21	-0.21	-0.04	-2.14	-1.46
Debt / FCF Ratio	-0.26	-0.26	-0.06	-5.55	-4.53
Quick Ratio	1.62	1.62	10.03	0.10	0.01
Current Ratio	1.77	1.77	10.51	0.11	0.01
Asset Turnover	0.27	0.27	0.00	0	-
Interest Coverage	-212.23	-212.23	-2.22	-5.31	-18.01
Return on Equity (ROE)	-107.20%	-107.20%	330.50%	41.00%	-
Return on Assets (ROA)	-84.10%	-84.10%	-114.30%	-791.30%	-
Return on Capital (ROIC)	-123.93%	-123.93%	-35.51%	49.86%	51.41%
Earnings Yield	-26.61%	-56.80%	-60.89%	-	-
FCF Yield	-20.32%	-43.37%	-32.04%	-	-
Buyback Yield / Dilution	-94.43%	-94.43%	-68.17%	-0.01%	-
Total Shareholder Return	-94.43%	-94.43%	-68.17%	-0.01%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).